Senior insider sale
CHIEF MEDICAL OFFICER at OLEMA PHARMACEUTICALS, INC. — senior position signals high conviction
$7.53M
269.51K shares
ZOJWALLA NASEEM plans to sell 269.51K shares of OLEMA PHARMACEUTICALS, INC. valued at approximately $7.53M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Options Granted - 02/01/2022
Cash
Stock Option Exercise
Cash
Restricted Stock Vesting
Compensation
Restricted Stock Vesting
Compensation
ESPP Purchase
Cash
Stock Option Exercise
Cash
Stock Option Exercise
Cash
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/23/2025 | Options Granted - 02/01/2022 Cash | 50K | — |
12/16/2024 | Stock Option Exercise Cash | 14K | — |
12/10/2024 | Restricted Stock Vesting Compensation | 11.48K | — |
12/9/2024 | Restricted Stock Vesting Compensation | 12.72K | — |
6/28/2024 | ESPP Purchase Cash | 1.49K | — |
5/24/2024 | Stock Option Exercise Cash | 9.46K | — |
3/18/2024 | Stock Option Exercise Cash | 364.00 | — |
| Total | 99.51K | ||
Completed
Units to sell
100K
Market value
$2.80M
Units to sell
70K
Market value
$1.97M
Planned — Approximate Date
Units to sell
99.51K
Market value
$2.75M
Units
269.51K
Value
$7.53M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/22/2025 | 100K | $2.80M | — | Completed |
12/19/2025 | 70K | $1.97M | — | Completed |
| Planned — Approximate Date | ||||
12/23/2025 | 99.51K | $2.75M | NASDAQ | Planned |
| Total | 269.51K | $7.53M | ||